Immunogenic and Protective Properties of Recombinant Proteins Based on Meningococcal Iga1 Protease
Received Date: Oct 07, 2015 / Accepted Date: Dec 08, 2015 / Published Date: Dec 15, 2015
Abstract
Recombinant proteins (M1K2–N963-LEH6, MA28–N963-LEH6 and ME135–H328-LEH6) have been created on the basis of the genome sequence of IgA1 protease of N. meningitidis serogroup B strain H44/76. It is revealed that, similarly to the native enzyme isolated earlier from N. meningitidis serogroup A strain A208, these proteins induce formation of animal protection against the infection with the virulent strain of meningococcus serogroup B. It is shown that these compounds are promising as a basis for a polyvalent anti-meningococcal vaccine.
Keywords: IgA1 protease; Recombinant proteins; Meningococcus; Immunogenicity; Protectivity
Citation: Zinchenko AA, Alliluev AP, Serova OP, Gordeeva EA, Zhigis LS, et al. (2015) Immunogenic and Protective Properties of Recombinant Proteins Based on Meningococcal Iga1 Protease. J Meningitis 1:102. Doi: 10.4172/2572-2050.1000102
Copyright: ©2015 Zinchenko AA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Tools
Article Usage
- Total views: 11586
- [From(publication date): 7-2016 - Jul 01, 2024]
- Breakdown by view type
- HTML page views: 10831
- PDF downloads: 755
